Where does Alignedbio AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alignedbio AB ranks #44,583 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Alignedbio AB hold?

Alignedbio AB holds 5 US utility patents granted between 2021 and 2023, spanning 11 technology areas.

What is Alignedbio AB's Innovation Score?

Alignedbio AB has an Innovation Score of 37.9 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Alignedbio AB's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Alignedbio AB.

What does claim depth mean for Alignedbio AB's patents?

Alignedbio AB's patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Alignedbio AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alignedbio AB

Q: What technology areas does Alignedbio AB focus on?

Alignedbio AB's top technology area is B82Y (Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures) with 3 patents, ranking #580 of 1,598 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 11 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B82Y (Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alignedbio ranks #44,583 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 11 technology areas.

#44,583
of 49,997 US assignees by volume: Top 42%
by Innovation Score (37.9/100): 16.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R44583 · Foreign Corporation #44,583 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
LOWER-Q #44,583/49,997
PHOTO-FINISH Alere
CPC-FOCUS B82Y · 11 areas
INNOV-THIN 37.9/100
CLAIMS-RICH 16.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2023 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Alere Technologies GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alignedbio’s 37.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (16%) Velocity 10.0 pts (26%) Breadth 11.7 pts (31%) Claim depth 10.0 pts (26%)

Qualcomm Incorporated · highest

85
Alignedbio AB · this assignee

38
3D Lighting… · lowest

7

What this shows Alignedbio's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Alignedbio?

Each dot is one of Alignedbio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alignedbio’s own 16.6 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Alignedbio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alignedbio's grants concentrate

Alignedbio AB is a focused PatentsView assignee: 11 CPC subclasses with 60% of grants classified under B82Y (Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2023. By volume, Alignedbio sits between Alere Technologies GMBH and Allflex Australia PTY Limited.

Alignedbio's three-year grant acceleration

Alignedbio AB shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Alere

5
Alerje

5
Alex IS THE Best

5
Algra S P A

5
Alite

5
Allanson Lighting

5
Alldata

5
Allflex Australia…

5
Alignedbio AB ◀

5

What this shows Alignedbio holds 5 patents at rank #44,486, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alignedbio

By rank, the assignees closest to #44,486 in granted patent volume.

Leaders in B82Y (Specific Uses OR Applications OF Nanostructures)

Other assignees with the most granted patents in Alignedbio's primary technology class.

Alignedbio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Alignedbio AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	40.0%
2022	2	40.0%
2023	1	20.0%

Which technologies does Alignedbio AB patent most?

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 3

C30B - Single-crystal Growth ; Unidirectional Solidification OF Eutectic Material OR Unidirectional Demixing OF Eutectoid MATERIAL; Refining BY Zone-melting OF Material ; Production OF A Homogeneous Polycrystalline Material With Defined Structure ; Single Crystals OR Homogeneous Polycrystalline Material WI 2

Y10T - Technical Subjects Covered BY Former US Classification 2

C23C - Coating Metallic MATERIAL; Coating Material With Metallic MATERIAL; Surface Treatment OF Metallic Material BY Diffusion Into THE Surface, BY Chemical Conversion OR SUBSTITUTION; Coating BY Vacuum Evaporation, BY Sputtering, BY ION Implantation OR BY Chemical Vapour Deposition, IN General 2

H10D - Inorganic Electric Semiconductor Devices 2

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 2

H10K - Organic Electric Solid-state Devices 2

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 2

H10F - Inorganic Semiconductor Devices Sensitive TO Infrared Radiation, Light, Electromagnetic Radiation OF Shorter Wavelength OR Corpuscular Radiation 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Alignedbio AB's patent record in context - here's where to go next.

Alignedbio AB's lead technology class is B82Y (Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures), 60% of its portfolio - see every assignee active in that class. Explore B82Y
Ranked #44,583 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alignedbio AB against Alere Technologies GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.